<DOC>
	<DOCNO>NCT02057146</DOCNO>
	<brief_summary>Single operater pancreatico-cholangioscopy perform work channel conventional duodenoscopes . A visual evaluation biliary pancreatic ductal system complete obvious suspicious macroscopic lesion target biopsy forceps . Evaluation usefulness probe base confocal laser endomicroscopy evaluation suspect premalignant lesion biliary duct pancreas .</brief_summary>
	<brief_title>Endoscopic Evaluation Premalignant Lesions Biliary Tract Pancreatic Ducts</brief_title>
	<detailed_description>Diagnosis early preneoplastic lesion always problem , especially come hidden organ bile duct pancreas . The recent development endoscopy encompass mini endoscope ( mother-baby ; `` SpyglasÂ® '' ) , allow visualization bile ducts pancreas possibility take biopsy direct vision . An even new technique adaptation exist confocal laser scan microscopy ( CLSM ) small probe , fit 1 mm work channel Spyglas . This application CLSM coin probe-based confocal laser endomicroscopy ( pCLE ) . It aim project systematically prospectively evaluate usefulness pCLE two distinct patient group : patient PSC prone develop bile duct cancer ( CCC ) patient chronic pancreatitis/family history pancreatic cancer prone develop pancreatic cancer suspect IPMN . Patients &amp; Methods Patients suspect diagnosis PSC undergo ERCP diagnosis therapy suspect CCC receive Spyglass investigation current clinical protocol . The investigator add pCLE patient . Patients chronic ( hereditary ) pancreatitis suspect malignancy , patient suspect premalignant lesion ( e.g . IPMN ) , individual risk familiar pancreatic cancer syndrome surveillance ( MRCP secretin ) demonstrate pancreatic pathology undergo ERCP Spyglass diagnostic procedure . In patient , investigator add pCLE . Spyglass introduce ERCP duct visually inspect . In area stenosis and/or suspect pathology , pCLE execute . Finally , area biopsied , possible . Bile pancreatic juice take cytology molecular analysis . Diagnostic yield accuracy determine ERCP ( x-ray ) , Spyglas , CLSM , histology ( PAD ) . This firstly explorative study diagnostic criterion assess malignancy CLSM development investigator group one Spyglas routinely contribute establish criterion . For statistical calculation , total 100 patient necessary . It plan prospectively together several center diagnostic criterion set order fulfill statistical need number . Significance An early diagnosis CCC develop PSC patient PDAC develop CP , IPMN patient individual familiar history PDAC would allow u treat patient good time surgery transplantation ( LTX ) . This , turn , way improve diagnosis tumor amongst bad prognosis solid tumor man .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<criteria>Suspicious lesion hepatobiliary pancreatic duct system . Unwillingness participate Unfit investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>PSC</keyword>
	<keyword>mother-baby endoscopy</keyword>
	<keyword>ERCP</keyword>
	<keyword>IPMN</keyword>
</DOC>